Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 35

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Mechanisms of Heteroresistance and Resistance to Imipenem in Pseudomonas aeruginosa

Xu, Ye, Zheng, Xiangkuo, Zeng, Weiliang, Chen, Tao, Liao, Wenli, Qian, Jiao, Lin, Jie, Zhou, Cui, Tian, Xuebin, Cao, Jianming, Zhou, Tieli · 2020 · Infection and Drug Resistance

Abstract

Background: Heteroresistance is a phenomenon that occurs in all bacteria and can cause treatment failure. Yet, the exact mechanisms responsible for heteroresistance still remain unknown. The following study investigated the mechanisms of imipenem-heteroresistance and -resistance in Pseudomonas aeruginosa clinical isolates from Wenzhou, China. Methods: Imipenem resistance was detected by the agar dilution method; heteroresistance was determined by population analysis profiles. Biofilm formation assay and modified carbapenem inactivation methods were also performed. Polymerase chain reaction (PCR) was conducted to detect oprD , and quantitative real-time PCR was used to determine expression levels of oprD, ampC and four efflux pump coding genes ( mexB, mexD, mexE and mexY ). Results: Six imipenem-heteroresistant and -resistant P. aeruginosa isolates were selected respectively. Deficient oprD was detected in all resistant isolates and two heteroresistant isolates. No strains produced carbapenemases. Expression levels of oprD were down-regulated in heteroresistant isolates. Transcription levels of the mexE and mexY were significantly increased in all heterogeneous subpopulations compared with their respective native ones. Compared with the susceptible group, increased mean relative expression levels of mexE and mexY or the decreased mean relative expression levels of oprD were observed in the resistant group ( P < 0.05), whereas transcription levels of the mexB and mexD remained unchanged. Conclusion: Down-regulation of oprD contributed to the resistance and heteroresistance of imipenem in our P. aeruginosa clinical isolates. In addition, the marginal up-regulation of efflux systems may indirectly affect imipenem resistance. Contrarily, defective oprD was less common in our experimental heteroresistant strains than resistant strains. Keywords: Pseudomonas aeruginosa , imipenem, resistance, heteroresistance, molecular mechanism, oprD

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2147/idr.s249475

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 35

  1. Oikonomou, 2011, J Med Microbiol, 60, 1556, 10.1099/jmm.0.032276-0 · DOI
  2. Quale, 2006, Antimicrob Agents Chemother, 50, 1633, 10.1128/aac.50.5.1633-1641.2006 · DOI · Paper page
  3. El-Domany, 2017, Microbial Drug Resist, 23, 682, 10.1089/mdr.2016.0234 · doi:10.1089/mdr.2016.0234
  4. Alexander, 1948, Am J Dis Child, 75, 428
  5. Nicoloff, 2019, Nat Microbiol, 4, 504, 10.1038/s41564-018-0342-0 · DOI · Paper page
  6. Band, 2019, PLoS Pathog, 15, e1007726, 10.1371/journal.ppat.1007726 · DOI · Paper page
  7. Fernandez Cuenca, 2012, Int J Antimicrob Agents, 39, 472, 10.1016/j.ijantimicag.2012.01.015 · DOI
  8. da Silva, 2018, Eur J Clin Microbiol Infect Dis, 37, 185, 10.1007/s10096-017-3138-x · DOI
  9. Tato, 2010, J Clin Microbiol, 48, 4089, 10.1128/jcm.01130-10 · DOI
  10. Sun, 2015, Clin Microbiol Infect, 21, 10.1016/j.cmi.2014.12.013 · DOI
  11. Mei, 2015, Int J Clin Exp Med, 8, 6129
  12. Band, 2016, Nat Microbiol, 1, 16053, 10.1038/nmicrobiol.2016.53 · DOI · Paper page
  13. Lee, 2011, Int J Antimicrob Agents, 37, 302, 10.1016/j.ijantimicag.2010.12.015 · DOI
  14. Lister, 2009, Clin Microbiol Rev, 22, 582, 10.1128/cmr.00040-09 · DOI · Paper page
  15. Kohler, 1999, Antimicrob Agents Chemother, 43, 424, 10.1128/AAC.43.2.424 · DOI · Paper page
  16. He, 2018, Int J Antimicrob Agents, 51, 413, 10.1016/j.ijantimicag.2017.10.014 · DOI
  17. Ikonomidis, 2008, FEMS Microbiol Lett, 279, 36, 10.1111/j.1574-6968.2007.00997.x · DOI · Paper page
  18. Tenover, 1995, J Clin Microbiol, 33, 2233, 10.1128/JCM.33.9.2233-2239.1995 · DOI · Paper page
  19. Yin, 2018, Front Microbiol, 9, 1135, 10.3389/fmicb.2018.01135 · DOI
  20. Singh, 2017, Can J Microbiol, 63, 929, 10.1139/cjm-2017-0380 · DOI
  21. Tomas, 2010, Antimicrob Agents Chemother, 54, 2219, 10.1128/aac.00816-09 · DOI
  22. Rossi Goncalves, 2017, Braz J Microbiol, 48, 211, 10.1016/j.bjm.2016.11.004 · DOI
  23. Nielsen, 2013, Pharmacol Rev, 65, 1053, 10.1124/pr.111.005769 · DOI · Paper page
  24. Lin, 2019, Antimicrob Agents Chemother, 63, 10.1128/aac.00556-19 · DOI
  25. Superti, 2009, Rev Inst Med Trop Sao Paulo, 51, 111, 10.1590/s0036-46652009000200010 · DOI
  26. Rodriguez-Martinez, 2009, Antimicrob Agents Chemother, 53, 4783, 10.1128/aac.00574-09 · DOI · Paper page
  27. Shu, 2017, J Antimicrob Chemother, 72, 2489, 10.1093/jac/dkx158 · doi:10.1093/jac/dkx158
  28. Fang, 2014, Infect Genet Evol, 21, 124, 10.1016/j.meegid.2013.10.027 · DOI
  29. Kim, 2016, J Microbiol, 54, 44, 10.1007/s12275-016-5562-5 · doi:10.1007/s12275-016-5562-5
  30. Yoon, 2019, J Antimicrob Chemother, 74, 2774, 10.1093/jac/dkz245 · DOI
  31. Shu, 2015, Microbial Drug Resist, 21, 149, 10.1089/mdr.2014.0116 · doi:10.1089/mdr.2014.0116
  32. Huang, 1995, Mol Microbiol, 16, 931, 10.1111/j.1365-2958.1995.tb02319.x · DOI
  33. Li, 2012, Int J Med Microbiol, 302, 63, 10.1016/j.ijmm.2011.10.001 · DOI · Paper page
  34. Rojo-Bezares, 2014, Int J Med Microbiol, 304, 405, 10.1016/j.ijmm.2014.01.001 · DOI
  35. Kohler, 1997, Mol Microbiol, 23, 345, 10.1046/j.1365-2958.1997.2281594.x · DOI · Paper page

Cited by

See all 35

Metadata

Authors
Xu, Y., Zheng, X., Zeng, W., Chen, T., Liao, W., Qian, J., Lin, J., Zhou, C., Tian, X., Cao, J., & Zhou, T.
Venue
Infection and Drug Resistance
Published
2020-05
Volume
Volume 13
Pages
1419-1428
ISSN
1178-6973
Cited by
35
References
2
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.